Bristol-Myers Squibb to acquire Celgene in deal worth $74 billion
Posted on07 Jan 2019
Comments0
BMS - Celgene acquisition deal
Bristol-Myers Squibb, Infinity Pharma ink clinical collaboration deal
Posted on06 Nov 2018
Comments0
Bristol-Myers Squibb Company and Infinity Pharmaceuticals, Inc. announced a clinical trial collaboration to evaluate Bristol-Myers Squibb’s Opdivo in combination with Infinity’s IPI-549... Read More
Eiger BioPharmaceuticals to Develop BMS’ Lambda for HDV
Posted on23 Apr 2016
TagsBristol-Myers Squibb, Eiger BioPharmaceuticals, HDV infection, hepatitis delta virus, Lonafarnib, Merck
Comments0
Eiger BioPharmaceuticals, Inc, a clinical-stage biopharmaceutical company, announced that it has licensed Pegylated Interferon Lambda-1a (Lambda), a novel, well-characterized, first in class... Read More
CHAI announces partnership with governments in six low- and middle-income countries to initiate and expand hepatitis C treatment programs
Ministries of Health in Ethiopia, Indonesia, Myanmar, Nigeria, Rwanda, and Vietnam are accelerating access to hepatitis C (HCV) testing and treatment with... Read More
ViiV Healthcare acquires late-stage HIV R&D assets from BMS
GlaxoSmithKline plc, one of the world’s leading research-based pharmaceutical and healthcare companies, announced that ViiV Healthcare, the global specialist HIV company majority... Read More
Bristol-Myers Squibb to Acquire Cardioxyl Pharma
Bristol-Myers Squibb and Cardioxyl Pharmaceuticals, Inc. announced that the companies have signed a definitive agreement under which Bristol-Myers Squibb will acquire all... Read More
Novozyme Ranked 1 in among top 20 global biotech employers for 2015
Posted on03 Nov 2015
TagsAbbott, AbbVie, Alexion Pharmaceuticals, Bayer, Biocon, Biogen, Boehringer Ingelheim, Bristol-Myers Squibb, Celgene, Eli Lilly, Genentech, gilead, Merck KGaA, Moderna Therapeutics, Monsanto Company, Novozymes, Regeneron Pharmaceuticals Novo Nordisk, Roche—excluding Genentech, Top 10 Biotech company globally, vertex pharmaceuticals
Comments0
Novozymes has earned 1st rank globally on top biotechnology employers in the world as ranked by American Association for the Advancement of Science (AAAS).... Read More
BMS gets rights to acquire Promedior & its anti-fibrosis drug, PRM-151
Bristol-Myers Squibb Company and Promedior, Inc., have entered into an agreement that grants Bristol-Myers Squibb an exclusive right to acquire Promedior and... Read More
R-PHARM US Acquires IXEMPRA(R) (ixabepilone) From Bristol-Myers Squibb and Launches U.S. Commercial Operations
R-PHARM US announces the acquisition of IXEMPRA (ixabepilone) from Bristol-Myers Squibb (BMY). IXEMPRA received marketing approval from the U.S. Food and Drug... Read More